Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism | Drug and Therapeutics Bulletin

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Review

Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism

Online download statistics by month:

Online download statistics by month: December 2018 to June 2021

	Abstract	Full	Pdf
Dec 2018	1558	40	30
Jan 2019	1154	61	32
Feb 2019	433	16	14
Mar 2019	194	9	6
Apr 2019	114	4	3
May 2019	104	6	5
Jun 2019	133	8	6
Jul 2019	164	5	2
Aug 2019	134	2	4
Sep 2019	120	7	4
Oct 2019	167	6	2
Nov 2019	88	7	0
Dec 2019	94	5	1
Jan 2020	284	6	3
Feb 2020	154	13	9
Mar 2020	119	2	1
Apr 2020	166	4	5
May 2020	151	6	6
Jun 2020	128	2	8
Jul 2020	81	1	1
Aug 2020	95	2	1
Sep 2020	100	2	3
Oct 2020	72	1	1
Nov 2020	62	3	2
Dec 2020	54	2	2
Jan 2021	61	2	1
Feb 2021	140	2	8
Mar 2021	124	2	5
Apr 2021	122	2	2
May 2021	55	1	3
Jun 2021	23	1	0
Total	6448	230	170